Ser165
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser165  -  JPH2 (human)

Site Information
PLRTsLssLRsEHsN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 4779179

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 ) , mutation of modification site ( 2 ) , western blotting ( 2 )
Disease tissue studied:
breast cancer ( 1 )
Relevant cell line - cell type - tissue:
myoblast ( 2 ) , SKBr3 (breast cell) ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKCA (human) ( 2 )

References 

1

Imami K, et al. (2012) Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics 11, 1741-57
22964224   Curated Info

2

Woo JS, et al. (2012) Hypertrophy in skeletal myotubes induced by junctophilin-2 mutant, Y141H, involves an increase in store-operated Ca2+ entry via Orai1. J Biol Chem 287, 14336-48
22389502   Curated Info